BioSpace News Archive

Pharm Country

Realm Therapeutics Highlights Strong 2017 Performance and Outlines 2018 Milestones

Realm Therapeutics today provided a clinical and business update.

February 15, 2018

·

5 min read

Spectrum Pharmaceuticals to Present Corporate Update at the 2018 RBC Capital Markets Global Healthcare Conference on February 22nd

The Company presentation is on Thursday, February 22, 2018, at 10:30 AM ET.

February 15, 2018

·

3 min read

Biotech Beach

MabVax Therapeutics Schedules Previously Announced 1-for-3 Reverse Stock Split to Regain Compliance with NASDAQ’s $1.00 Minimum Bid Price Maintenance Requirement

There is no guarantee that the Company will successfully regain compliance.

February 15, 2018

·

6 min read

Business

Imprimis Pharma to Host its Fourth Quarter 2017 Financial Report Conference Call and Webcast on March 8, 2018 at 4:30 p.m. EST

The company will host a conference call at 4:30 p.m. EST/1:30 p.m. PST on the same day to discuss the financial results and recent business developments.

February 15, 2018

·

3 min read

Business

Celgene Elects John Weiland to Its Board of Directors

Weiland has over 30 years in the healthcare industry and was most recently the President and Chief Operating Officer of C.R. Bard (Bard).

February 15, 2018

·

3 min read

Drug Development

Omeros Reports Significant Improvement in Overall Survival Data in OMS721-Treated Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

The data demonstrate an increase in median overall survival in HCT-TMA patients treated with OMS721 compared to a matched historical control (347 days vs. 21 days, respectively, by Kaplan-Meier analysis; p < 0.0001 by log-rank test).

February 15, 2018

·

12 min read

Business

Zoetis Reports Fourth Quarter and Full Year 2017 Results

The company reported revenue of $1.5 billion for the fourth quarter of 2017, which was an increase of 14% compared with the fourth quarter of 2016.

February 15, 2018

·

39 min read

Policy

Edwards’ Self-Expanding Transcatheter Heart Valve Receives CE Mark

The Edwards CENTERA valve is repositionable and retrievable and can be delivered through a low-profile, 14-French, motorized delivery system.

February 15, 2018

·

3 min read

Drug Development

Eisai Reports Positive Phase III Trial Results of Investigational Anticancer Agent Lenvatinib in Unresectable Hepatocellular Carcinoma Published in The Lancet

The REFLECT study reported on in the paper was a multicenter, open-label, randomized, global Phase 3 study comparing the efficacy and safety of lenvatinib versus sorafenib.

February 15, 2018

·

16 min read

Business

Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2017 Investor Update

Ironwood ended 2017 with approximately $221 million of cash, cash equivalents and available-for-sale securities.

February 15, 2018

·

41 min read